OptiCept Technologies (OPTI) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
6 Jun, 2025Executive summary
Achieved strong commercialization progress in Q1 2025, with positive results in forestry, foodtech, and planttech segments.
Secured breakthrough orders in Chile and Spain, and signed a major agreement with a leading Indonesian forestry company.
Appointed Henrik Nettersand as CFO and received a new European patent for food processing technology.
Secured SEK 37 million in post-period financing to support expansion and target positive cash flow.
Financial highlights
Net revenue for Q1 2025 was SEK 8,199 thousand, up from SEK 5,909 thousand year-over-year.
Net sales reached SEK 5,278 thousand (Q1 2024: SEK 3,598 thousand); FoodTech contributed SEK 5,054 thousand, PlantTech SEK 224 thousand.
EBITDA was SEK -12,415 thousand (Q1 2024: SEK -11,495 thousand); net result for the period was SEK -15,962 thousand (Q1 2024: SEK -14,804 thousand).
Cash flow from operating activities was SEK -10,229 thousand (Q1 2024: SEK -9,653 thousand); cash and cash equivalents at period end were SEK 6,883 thousand.
Equity ratio remained strong at 92% (Q1 2024: 92%).
Outlook and guidance
Well positioned for positive cash flow, with further key orders expected in olive oil, juice, and solid foods segments.
Evaluation projects in forestry cuttings expected to conclude in fall 2025, with significant growth potential.
Expansion plans depend on liquidity and successful execution of sales forecasts; additional financing may be needed if timelines are delayed.
Latest events from OptiCept Technologies
- Yield-boosting tech and new partnerships fuel growth and positive EBITDA prospects for 2026.OPTI
DNB Carnegie Småbolagsdag2 Dec 2025 - Positive EBITDA achieved in Q3 2025, with strong sales and improved margins year-over-year.OPTI
Q3 202521 Nov 2025 - Strong order intake and new financing drive expansion despite lower sales and earnings.OPTI
Q2 202529 Aug 2025 - Revenue up, losses down, and new funding to accelerate global commercialization.OPTI
Q3 202413 Jun 2025 - Record order book and strong sales growth drive improved results and global expansion.OPTI
Q2 202413 Jun 2025 - Revenue growth, improved margins, and new partnerships drive optimism for 2025.OPTI
Q4 20245 Jun 2025